# Smith & Nephew

Type: Company (SNN)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/smith-nephew
Canonical HTML page: https://getbiobrief.com/entity/smith-nephew

## Recent coverage (2 stories)

### German NPWT Consensus Backs 7-Day PICO7 Therapy, Aims to Slash Surgical Costs
2026-08-01 06:53:44 · Sentiment: Positive · Impact: 6/10 · Sources: 2

German expert panel validates single-use NPWT for surgical incisions, reinforcing the economic case for Smith & Nephew's PICO7. The guidance, published in Die Chirurgie, emphasizes reduced hospital stays and complication costs, a potential tailwind for device adoption in the EU's largest market.
Full story: https://getbiobrief.com/story/german-npwt-consensus-pico7-surgical-costs

### Smith & Nephew Sets Ambitious 2028 Targets Following Q4 Results
2026-03-02 12:15:20 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Smith & Nephew (SNN) has reported its fourth-quarter results and provided a multi-year financial outlook through 2028, signaling a pivot toward sustained growth. The company is leveraging strategic partnerships, including a collaboration with SI-BONE, to expand its footprint in high-growth medtech segments.
Full story: https://getbiobrief.com/story/smith-nephew-q4-results-2028-outlook

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.